While the Omicron variant was not in circulation during the Evusheld clinical trials, the company added that it is continuing to collect further data to better understand the implications of this data in clinical practice. The findings from both studies were posted online on preprint server bioRxiv, and not peer-reviewed yet.
Surviving The 2nd Wave of Corona
‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort